C Heuser Selected Research

Melanoma (Melanoma, Malignant)

1/2001

A novel strategy in the elimination of disseminated melanoma cells: chimeric receptors endow T cells with tumor specificity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C Heuser Research Topics

Disease

3	Neoplasms (Cancer) 09/2003 - 01/2001
1	Heart Failure 06/2019
1	Breast Neoplasms (Breast Cancer) 09/2003
1	Neoplasm Micrometastasis 01/2001
1	Inflammation (Inflammations) 01/2001
1	Discoid Lupus Erythematosus 01/2001
1	Melanoma (Melanoma, Malignant) 01/2001
1	Glioma (Gliomas) 05/2000

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 09/2003 - 05/2000
2	AntigensIBA 09/2003 - 01/2001
1	Mucin-1 (CA 15-3 Antigen)IBA 09/2003
1	Interleukin-2 (IL2)IBA 12/2001
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2001
1	HMW-MAAIBA 01/2001
1	Chimeric Antigen ReceptorsIBA 01/2001
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2001
1	Peptides (Polypeptides)IBA 01/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2001
1	Interleukin-15 (Interleukin 15)IBA 01/2001
1	Ganciclovir (Cytovene)FDA LinkGeneric 05/2000
1	ProdrugsIBA 05/2000
1	4-ipomeanolIBA 05/2000

Therapy/Procedure

2	Immunotherapy 09/2003 - 01/2001
1	Therapeutics 06/2019
1	Drug Therapy (Chemotherapy) 01/2001